Regulation of Parkin E3 ubiquitin ligase activity

Cellular and Molecular Life Sciences

Volumn 69, Issue 18, 2012, Pages 3053-3067

  Walden, Helen ^a   Martinez Torres, R Julio ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Cancer; Mitochondria; Mitophagy; Neurodegeneration; Parkinson's disease; Posttranslational modification; Regulation; Ubiquitination

Indexed keywords

14 3 3 ETA PROTEIN; BCL 2 ASSOCIATESD ATHANOGENE 5; CARRIER PROTEINS AND BINDING PROTEINS; MULTIPROTEIN COMPLEX; PARKIN; PHOSPHOTRANSFERASE; PROTEIN 14 3 3; PTEN INDUCED KINASE 1; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; HUMAN; NEDDYLATION; NITROSYLATION; NONHUMAN; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; UBIQUITINATION;

HUMANS; MITOCHONDRIA; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN-PROTEIN LIGASES;

EUKARYOTA;

EID: 84865656962     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-0978-5     Document Type: Review

References (142)

1. Gasser T (2007) Update on the genetics of Parkinson's disease. Mov Disord 22(Suppl 17):S343-S350 (Pubitemid 350134187)
2. Hardy J (2010) Genetic analysis of pathways to Parkinson disease. Neuron 68:201-206
3. Bonifati V (2012) Autosomal recessive Parkinsonism. Parkinsonism Relat Disord 18(Suppl 1):S4-S6
4. Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 111:145-151 (Pubitemid 36105909)
5. Dawson TM, Dawson VL (2010) The role of parkin in familial and sporadic Parkinson's disease. Mov Disord 25(Suppl 1):S32-S39
6. Devine MJ, Plun-Favreau H, Wood NW (2011) Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer 11:812-823
7. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
8. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R et al (2003) Parkin, a gene implicated in autosomal recessive juvenile Parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci USA 100:5956-5961 (Pubitemid 36581860)
9. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E et al (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 42:77-82
10. Weir BA, Woo MS, Getz G, Perner S, Ding L et al (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898 (Pubitemid 350231325)
11. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392:605-608 (Pubitemid 28207717)
12. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S et al (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302-305 (Pubitemid 30437317)
13. Hristova VA, Beasley SA, Rylett RJ, Shaw GS (2009) Identification of a novel Zn2?-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem 284:14978-14986
14. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31:763-780
15. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL et al (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97:13354-13359
16. Komander D (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37:937-953
17. Emmerich CH, Schmukle AC, Walczak H (2011) The emerging role of linear ubiquitination in cell signaling. Sci Signal 4:re5
18. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y et al (2009) Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137:133-145
19. Hoeller D, Hecker CM, Dikic I (2006) Ubiquitin and ubiquitinlike proteins in cancer pathogenesis. Nat Rev Cancer 6:776-788 (Pubitemid 44450466)
20. Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275-286
21. Spence J, Sadis S, Haas AL, Finley D (1995) A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol 15:1265-1273
22. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E et al (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591-596
23. Tokunaga F, Nakagawa T, Nakahara M, SaekiY, TaniguchiMet al (2011) SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471:633-636
24. Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C et al (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471:637-641
25. Ulrich HD, Walden H (2010) Ubiquitin signalling in DNA replication and repair. Nat Rev Mol Cell Biol 11:479-489
26. Winget JM, Mayor T (2010) The diversity of ubiquitin recognition: hot spots and varied specificity. Mol Cell 38:627-635
27. Chew KC, Matsuda N, Saisho K, Lim GG, Chai C et al (2011) Parkin mediates apparent E2-independent monoubiquitination in vitro and contains an intrinsic activity that catalyzes polyubiquitination. PLoS ONE 6:e19720
28. Matsuda N, Kitami T, Suzuki T, Mizuno Y, Hattori N et al (2006) Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro. J Biol Chem 281:3204-3209 (Pubitemid 43845931)
29. Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O (2006) Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum Mol Genet 15:2059-2075 (Pubitemid 43923396)
30. Periquet M, Corti O, Jacquier S, Brice A (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 95:1259-1276 (Pubitemid 41779252)
31. Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S et al (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12:1427-1437 (Pubitemid 36758455)
32. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H et al (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7:1144-1150 (Pubitemid 33010024)
33. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A et al (2001) Ubiquitination of a new form of alphasynuclein by parkin from human brain: implications for Parkinson's disease. Science 293:263-269 (Pubitemid 32694735)
34. Choi P, Snyder H, Petrucelli L, Theisler C, Chong M et al (2003) SEPT5-v2 is a parkin-binding protein. Brain Res Mol Brain Res 117:179-189
35. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y et al (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105:891-902 (Pubitemid 32635090)
36. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E et al (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37:735-749. (Pubitemid 36288547)
37. Hyun DH, Lee M, Halliwell B, Jenner P (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 86:363-373 (Pubitemid 36842435)
38. Ren Y, Zhao J, Feng J (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci 23:3316-3324 (Pubitemid 36531973)
39. Tsai YC, Fishman PS, Thakor NV, Oyler GA (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem 278:22044-22055 (Pubitemid 36792614)
40. Jiang H, Jiang Q, Feng J (2004) Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J Biol Chem 279:54380-54386 (Pubitemid 40053177)
41. Okui M, Yamaki A, Takayanagi A, Kudo h J, Shimizu N et al (2005) Transcription factor single-minded 2 (SIM2) is ubiquitinated by the RING-IBR-RING-type E3 ubiquitin ligases. Exp Cell Res 309:220-228 (Pubitemid 41191236)
42. Ko HS, von Coelln R, Sriram SR, KimSW, Chung KK et al (2005) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci 25:7968-7978 (Pubitemid 41254399)
43. Fallon L, Belanger CM, Corera AT, Kontogiannea M, Regan-Klapisz E et al (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 8:834-842 (Pubitemid 44151586)
44. Um JW, Min DS, Rhim H, Kim J, Paik SR et al (2006) Parkin ubiquitinates and promotes the degra dation of RanBP2. J Biol Chem 281:3595-3603 (Pubitemid 43845977)
45. Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE et al (2007) Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci 27:1868-1878
46. Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA et al (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178:1025-1038 (Pubitemid 47443324)
47. Fukae J, Sato S, Shiba K, Sato K, Mori H et al (2009) Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease. FEBS Lett 583:521-525
48. Chen D, Gao F, Li B, Wang H, Xu Y, et al. (2010) Parkin monoubiquitinates BCL-2 and regulates autophagy. J Biol Chem 285:38214-38223
49. Geisler S, Holm strom KM, Skujat D, Fiesel FC, Rothfuss OC et al (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12:119-131
50. Ziviani E, Tao RN, Whitworth AJ (2010) Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci USA 107:5018-5023
51. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL et al (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147:893-906
52. Shin JH, Ko HS, Kang H, Lee Y, Lee YI et al (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144:689-702
53. Joch M, Ase AR, Chen CX, MacDonald PA, Kontogiannea M et al (2007) Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol Biol Cell 18:3105-3118 (Pubitemid 47235315)
54. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C et al (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12:2277-2291 (Pubitemid 37160872)
55. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA et al (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628-43635 (Pubitemid 37345989)
56. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M et al (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci USA 101:10744-10749 (Pubitemid 38955813)
57. Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N et al (2005) Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14:71-84 (Pubitemid 40123464)
58. Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12:9-14
59. Pilsl A, Winklhofer KF (2012) Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease. Acta Neuropathol 123:173-188
60. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH et al (2010) Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19:4861-4870
61. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP et al (2011) Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS ONE 6:e16746
62. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L (2010) The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS ONE 5:e10054
63. Glauser L, Sonnay S, Stafa K, Moore DJ (2011) Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 118:636-645.
64. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF et al (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191:1367-1380
65. Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ et al (2011) Autoregulation of Parkin activity through its ubiquitinlike domain. EMBO J 30:2853-2867
66. Wenzel D.M. Lissounov A. Brzovic P.S. Klevit RE (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474:105-108.
67. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K et al (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189:211-221
68. Henn IH, Gostner JM, Lackner P, Tatzelt J, Winklhofer KF (2005) Pathogenic mutations inactivate parkin by distinct mechanisms. J Neurochem 92:114-122 (Pubitemid 40193514)
69. Cookson MR, Lockhart PJ, McLendon C, O'Farrell C, Schlossmacher M et al (2003) RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet 12:2957-2965 (Pubitemid 37442024)
70. Wang C, Ko HS, Thomas B, Tsang F, Chew KC et al (2005) Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum Mol Genet 14:3885-3897 (Pubitemid 43020090)
71. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K et al (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160 (Pubitemid 38661852)
72. Deas E, Wood NW, Plun-Favreau H (2011) Mitophagy and Parkinson's disease: The PINK1-parkin link. Biochim Biophys Acta 1813:623-633
73. Deas E, Plun-Favreau H, Wood NW (2009) PINK1 function in health and disease. EMBO Mol Med 1:152-165
74. Zhou H, Falkenburger BH, Schulz JB, Tieu K, Xu Z et al (2007) Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 3:242-250 (Pubitemid 46425506)
75. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A et al (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA 104:11441-11446 (Pubitemid 47175159)
76. Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH et al (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS ONE 4:e5777
77. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR et al (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-1166 (Pubitemid 43990738)
78. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB et al (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078-4083 (Pubitemid 36418160)
79. Park J, Lee SB, Lee S, Kim Y, Song S et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157-1161 (Pubitemid 43990737)
80. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y et al (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103:10793-10798 (Pubitemid 44078055)
81. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K et al (2009) Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284:22938-22951
82. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C et al (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27:12413-12418 (Pubitemid 350085485)
83. Kim Y, Park J, Kim S, Song S, Kwon SK et al (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377:975-980
84. Sha D, Chin LS, Li L (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19:352-363
85. Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795-803
86. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA et al (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8:e1000298
87. Sterky FH, Lee S, Wibom R, Olson L, Larsson NG (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci USA 108:12937-12942
88. Xiong H, Wang D, Chen L, Choo YS, Ma H et al (2009) Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 119:650-660.
89. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J et al (2010) Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29:3571-3589
90. Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M et al (2011) DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20:40-50
91. Lazarou M, Jin SM, Kane LA, Youle R (2012) Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell. doi:10.1016/j.bbr.2011.03.031
92. Petroski MD, Deshaies RJ (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9-20 (Pubitemid 40064895)
93. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N et al (2011) Structural regulation of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol 21:257-264
94. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T et al (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 10:55-67 (Pubitemid 34876562)
95. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ et al (1999) Identification of CHIP, a novel tetratricopeptide repeatcontaining protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19:4535-4545 (Pubitemid 29242026)
96. Jiang J, Ballinger CA, Wu Y, Dai Q, Cyr DM et al (2001) CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem 276:42938-42944
97. Van Humbeeck C, Waelkens E, Corti O, Brice A, Vandenberghe W (2008) Parkin occurs in a stable, non-covalent, approximately 110 kDa complex in brain. Eur J Neurosci 27:284-293
98. Sato S, Chiba T, Sakata E, Kato K, Mizuno Y et al (2006) 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J 25:211-221 (Pubitemid 43077309)
99. Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ et al (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron 44:931-945 (Pubitemid 39643090)
100. Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT et al (2011) Ubiquitinylation of alpha-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS ONE 6:e14695
101. UmJW,Chung KC (2006) Functionalmodulation of parkin through physical interaction with SUMO-1. J Neurosci Res 84:1543-1554
102. Shimura H, Hattori N, Kubo S, Yoshikawa M, Kitada T et al (1999) Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile Parkinsonism patients. Ann Neurol 45:668-672 (Pubitemid 29217599)
103. Stichel CC, Augustin M, Kuhn K, Zhu XR, Engels P et al (2000) Parkin expression in the adult mouse brain. Eur J Neurosci 12:4181-4194 (Pubitemid 32037829)
104. da Costa CA, Sunyach C, Giaime E, West A, Corti O et al (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 11:1370-1375
105. Trempe JF, Chen CX, Grenier K, Camacho EM, Kozlov G et al (2009) SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination. Mol Cell 36:1034-1047
106. Liu F, Walters KJ (2011) Policing Parkin with a UblD. EMBO J 30:2757-2758
107. Wickliffe KE, Lorenz S, Wemmer DE, Kuriyan J, Rape M (2011) The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144:769-781
108. Ye Y, Rape M (2009) Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 10:755-764
109. Komander D, Clague MJ, Urbe S (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10:550-563
110. Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ et al (2011) The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet 20:141-154
111. Costa MD, Paulson HL (2011) Toward understanding Machado-Joseph disease. Prog Neurobiol (in press)
112. Durcan TM, Fon EA (2011) Mutant ataxin-3 promotes the autophagic degradation of parkin. Autophagy 7:233-234
113. Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA (2012) Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin- conjugating enzyme. J Biol Chem 287:531-541
114. Kuroda Y, Sako W, Goto S, Sawada T, Uchida D, et al. (2012) Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. Hum Mol Genet 21:991-1003
115. Van Humbeeck C, Cornelissen T, Hofkens H, Mandemakers W, Gevaert K et al (2011) Parkin interacts with Ambra1 to induce mitophagy. J Neurosci 31:10249-10261
116. Kao SY (2009) DNA damage induces nuclear translocation of parkin. J Biomed Sci 16:67
117. Rankin CA, Roy A, Zhang Y, Richter M (2011) Parkin, a top level manager in the cell's sanitation department. Open BiochemJ 5:9-26
118. Rubio de la Torre E, Gomez-Suaga P, Martinez-Salvador M, Hilfiker S (2011) Posttranslational modifications as versatile regulators of parkin function. Curr Med Chem 18:2477-2485
119. Yamamoto A, Friedlein A, Imai Y, Takahashi R, Kahle PJ et al (2005) Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J Biol Chem 280:3390-3399 (Pubitemid 40223802)
120. Avraham E, Rott R, Liani E, Szargel R, Engelender S (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J Biol Chem 282:12842-12850 (Pubitemid 47100582)
121. Rubio de la Torre E, Luzon-Toro B, Forte-Lago I, Minguez-Castellanos A, Ferrer I et al (2009) Combined kinase inhibition modulates parkin inactivation. Hum Mol Genet 18:809-823
122. Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS et al (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci USA 107:16691-16696
123. Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF et al (2011) Novel regulation of parkin function through c-Ablmediated tyrosine phosphorylation: implications for Parkinson's disease. J Neurosci 31:157-163
124. Gu Z, Nakamura T, Lipton SA (2010) Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol 41:55-72.
125. Tsang AH, Lee YI, Ko HS, Savitt JM, Pletnikova O et al (2009) S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci USA 106:4900-4905
126. Nakamura T, Wang L, Wong CC, Scott FL, Eckelman BP et al (2010) Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell 39:184-195
127. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J et al (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186-1190 (Pubitemid 36193354)
128. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A et al (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324:102-105
129. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC et al (2004) S-Nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304:1328-1331 (Pubitemid 38697430)
130. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y et al (2004) Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA 101:10810-10814 (Pubitemid 38955824)
131. Meng F, Yao D, Shi Y, Kabakoff J, Wu W et al (2011) Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener 6:34
132. Winklhofer KF, Henn IH, Kay-Jackson PC, Heller U, Tatzelt J (2003) Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. J Biol Chem 278:47199-47208 (Pubitemid 37452306)
133. Nagy V, Dikic I (2010) Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol Chem 391:163-169
134. Um JW, Han KA, Im E, Oh Y, Lee K, et al. (2012) Neddylation positively regulates the ubiquitin E3 ligase activity of parkin. J Neurosci Res (in press)
135. Burchell L, Chaugule VK, Walden H (2012) Small, N-terminal tags activate Parkin E3 ubiquitin ligase activity by disrupting its autoinhibited conformation. PLoS ONE (in press)
136. Choo YS, Vogler G, Wang D, Kalvakuri S, Iliuk A et al (2012) Regulation of parkin and PINK1 by neddylation. Hum Mol Genet. doi:10.1093/hmg/dds070
137. Lim KL, Chew KC, Tan JM, Wang C, Chung KK et al (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 25:2002-2009 (Pubitemid 40289405)
138. Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B (2003) Parkin suppresses dopaminergic neuron-selective meurotoxicity induced by Pael-R in Drosophila. Neuron 37:911-924 (Pubitemid 36398298)
139. Huynh DP, Scoles DR, Nguyen D, Pulst SM (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin X.I. Hum Mol Genet 12:2587-2597 (Pubitemid 37304682)
140. Ko HS, Kim SW, Sriram SR, Dawson VL, Dawson TM (2006) Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. J Biol Chem 281:16193-16196
141. Wang H, Song P, Du L, Tian W, Yue W et al (2011) Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J Biol Chem 286:11649-11658
142. Corti O, Brice A (2007) Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin-protein ligase. Drug Discov Today Dis Mech 4:121-127